US Broker Ratings

Fortrea Holdings Inc. (FTRE) Valuation Insights: A 61.98% Potential Upside Amidst Challenging Metrics

Fortrea Holdings Inc. (NASDAQ: FTRE), a notable player in the biotechnology sector, is capturing investor attention with a significant potential upside despite facing some challenging financial..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unveiling a 217% Potential Upside in the Biotech Arena

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector with an impressive 217% potential upside, as suggested by analysts. Headquartered in Cambridge, Massachusetts,..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Growth and Investor Potential

LifeMD, Inc. (NASDAQ: LFMD) is making significant strides within the telehealth sector, a rapidly expanding segment of the healthcare industry. With a current market cap of..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Assessing the 25.96% Potential Upside

Sage Therapeutics, Inc. (NASDAQ: SAGE), a prominent player in the biotechnology sphere, is currently making waves in the healthcare sector with its focus on developing innovative..

AxoGen, Inc. (AXGN) Investor Outlook: Exploring a Promising 124% Potential Upside

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising potential upside of 124.12%...

Savara, Inc. (SVRA) Stock Analysis: A Biotech Prospect with a 271% Potential Upside

For investors eyeing the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) represents a compelling opportunity, particularly for those interested in companies focusing on rare respiratory diseases. With..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges for Potential Growth in Healthcare

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, particularly in the medical care facilities industry, provides essential home health and hospice services across the..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotechnology Innovator with a Stunning 221% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector. With a market capitalization of $418.34..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a 50% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI), a venerable name in the healthcare sector with roots dating back to 1882, presents a complex yet intriguing case for..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking the 140% Potential Upside in the Biotechnology Space

Septerna, Inc. (NASDAQ: SEPN) is drawing significant attention from the investor community, given its promising potential upside of 140.03%. As a clinical-stage biotechnology company, Septerna offers..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Uncovering a 41% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is captivating investors’ attention with a notable potential upside of over 41%, according to recent analyst ratings. As a specialty pharmaceutical..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 221% Potential Upside in Biotech

Inventiva S.A. (NASDAQ: IVA) is gaining attention among investors due to its promising biopharmaceutical pipeline and a staggering potential upside of over 221%, according to the..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Biopharma Player with 140% Upside Potential

For investors seeking a compelling opportunity in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands out with its remarkable potential for growth. This Cambridge, Massachusetts-based..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unpacking a 41% Potential Upside in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a burgeoning name in the healthcare sector, particularly in medical devices, is drawing investor attention with its impressive 41.14% potential upside...

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with its innovative approach to the discovery and development of engineered monoclonal antibodies, targeting a..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Insights into Nearly 98% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a prominent player in the biotechnology industry, focusing on nucleic acid production and biologics safety testing. With its headquarters..

Auna SA (AUNA) Stock Analysis: Strong Buy Ratings Signal Nearly 95% Upside Potential

For investors scouting the healthcare sector, Auna SA (AUNA), a Luxembourg-based healthcare service provider, presents a compelling opportunity. With operations spanning hospitals and clinics in Mexico,..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating the Waves of Revenue Decline and Market Potential

Investors eyeing the healthcare sector may find Semler Scientific, Inc. (NASDAQ: SMLR) an intriguing proposition, especially given its niche focus on medical devices for enhancing clinical..

Sonida Senior Living, Inc. (SNDA): Investor Outlook with 6.47% Potential Upside

Sonida Senior Living, Inc. (SNDA), a key player in the Healthcare sector under the Medical Care Facilities industry, presents a compelling case for individual investors seeking..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 23.46% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV), a notable player in the healthcare sector, primarily focuses on providing comprehensive medical and ancillary services for the elderly. With its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds